Treatment and Clinical Endpoints in Polycythemia Vera: Seeking the Best Obtainable Version of the Truth.
Sign Up to like & getrecommendations! Published in 2022 at "Blood"
DOI: 10.1182/blood.2022015680
Abstract: Polycythemia vera (PV) is a Philadelphia chromosome-negative myeloproliferative neoplasm driven by the JAK2 V617F (or rarely exon 12) mutation. Its natural history can extend over a few decades, and therefore treatment planning is predicated on… read more here.
Keywords: clinical endpoints; treatment clinical; polycythemia vera; treatment ... See more keywords